As a practitioner in an educational setting, you're likely aware of the immense challenges faced by pediatric brain tumor (PBT) survivors. The research article, Neurocognitive and Psychosocial Outcomes in Pediatric Brain Tumor Survivors, provides invaluable insights that can help you improve your therapy skills and make a meaningful impact on your students' lives.
Here are some key takeaways from the research that you can implement in your practice:
1. Understand the Core Deficits
The study highlights that core deficits in attention, processing speed, and working memory are common among PBT survivors. These deficits significantly impact their intellectual development, academic achievement, and career attainment. As a practitioner, you can focus on interventions that target these specific areas to help improve overall outcomes.
2. Implement Evidence-Based Interventions
Several intervention paradigms are briefly described in the research. While many are still in their early stages, some promising approaches include:
- Academic Accommodations: Ensure that students receive the necessary accommodations and modifications to support their learning needs.
- Cognitive Training: Utilize programs like Cogmed to improve working memory and other cognitive functions.
- Behavioral and Psychological Support: Provide ongoing psychological support to address emotional and behavioral health concerns.
3. Advocate for Comprehensive Care
The research emphasizes the importance of ongoing surveillance and comprehensive neuropsychological evaluations. Advocate for these services within your educational setting to ensure that students receive the care they need.
4. Encourage Further Research
While the current research provides a solid foundation, there is still a need for innovative and specific interventions to address the late effects of PBT treatment. Encourage further research in this area to continue improving outcomes for PBT survivors.
To read the original research paper, please follow this link: Neurocognitive and Psychosocial Outcomes in Pediatric Brain Tumor Survivors.